期刊文献+

非ST段抬高型急性冠状动脉综合征介入治疗的最佳时机 被引量:4

Best time for intervention in non ST segment elevation acute coronary syndrome
原文传递
导出
摘要 非ST段抬高型急性冠状动脉综合征(NSTEACS)中高危患者,早期介入和强化抗栓药物治疗是最佳选择,对于低危患者,早期介入或选择介入都可行。欧洲心脏病协会指南认为NSTEACS症状反复发作,并有高危因素,Grace风险评分>109分,推荐于发病72h内行介入治疗;Grace风险评分>140分,建议24h内行介入治疗;对并发难治性心绞痛、心力衰竭、恶性心律失常者建议发病2h内介入治疗。 High-risk patients with non-ST-segment elevation acute coronary syndrome(NSTEACS) are recommended to choose early intervention and strengthened antithrombotic drug therapy.While for low-risk patients,early or elective intervention are feasible.European Society of Cardiology guidelines suggested that if NSTEACS patients with recurrent symptoms,high risk factors and Grace risk score 109 points,intervention should be recommended within 72 h from the onset;if the grace risk score 140 points,the intervention should be recommended within 25 h from the onset;if NSTEACS patients complicated with refractory heart angina,heart failure,and malignant arrhythmia,the intervention is recommended within 2 h from the onset.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第1期15-18,共4页 Journal of Clinical Cardiology
关键词 冠状动脉综合征 急性 介入治疗 最佳时机 coronary syndrome acute intervention best time
  • 相关文献

参考文献20

  • 1Effects of tissue plasminogen activator and a compari son of early invasive and conservative strategies in un stable angina and non-Q-wave myocardial infarction. Results of the T1M1 Ill B Trial. Thrombolysis in myo cardial ischemia[J]. Circulation, 1994, 89:1545 - 1556.
  • 2MCCULI.OUGH P A, O'NEILI. W W, GRAHAM M, et al. A prospective randomized trial of triage an giography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial [J]. J Am Coil Cardiol,1998,32:596--605.
  • 3BODEN W E, O'ROURKE R A, CRAWFORI) M H, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strate gy. Veterans affairs non Q-wave infarction strategies in hospital (VANQWISH) trial investigators[J]. N Engl J Med,1998 , 338 :1785 -1792.
  • 4FRISC II Investigators. Invasive compared with noninvasive treatment in unstable coronary-artery disease: FRISC II prospective randomised muhicentre study. Fragmin and fast revascularisation during in stability in coronary artery disease investigators [J].Lancet, 1999,354:708--715.
  • 5HIRSCH A, WINDHAUSEN F, TIJSSEN J G, et al. Long term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevat ed cardiac troponin T (the 1CTUS trial): a follow-up study[J]. Lancet, 2007,369 : 827 -- 835.
  • 6CANNON C P, WEINTRAUB W S, DEMOPOU- LOS L A, et al. TACTICS (treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategy). Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early inva-sive and conservative strategies in patients with unsta- ble coronary syndromes treated with the glycoprotein lib/Ilia inhibitor tirofiba[J]. N Engl J Med, 2001, 344:1879--1887.
  • 7FOX K A, POOLE WII.SON P A, HENDERSON R A, et al. Randomized intervention trial of unstable angina investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial[J]. Lancet,2002,360:743-751.
  • 8BAVRY A A, KUMBHANI D J, RASSI A N, et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials[J]. J Am Coll Cardiol, 2006,48: 1319--1325.
  • 9SAVONITTO S, DE SERVI S, PETRONIO A S, et al. Early aggressive vs. initially conservative treatment in elderly patients with non ST-elevation acute coronary syndrome: the Italian Elderly ACS study [J].J Cardiovasc Med ( Hagerstown), 2008,9 : 217 -- 226.
  • 10NEUMANN F J, KASTRATI A, POGATSA-MURRAY G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial [J]. JAMA, 2003, 290: 1593--1599.

同被引文献23

  • 1刘广彬,彭永平,江时森.非ST段抬高型心肌梗死早期治疗策略的对比研究[J].医学研究生学报,2011,24(5):477-481. 被引量:15
  • 2David H,Fitchett,Pierre Theroux,James M,et al.Assessment and Management of Acute Coronary Syndromes (ACS):A Canadian Perspective on Current Guideline-Recommended Treatment-Part 1:Non-ST-Segment Elevation ACS[J].Canadian Journal of Cardiology,2011(27):387-401.
  • 3Jean-Pierre Bassand,et.al,Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes[J].European Heart Journal,2007,28,1598-1660.
  • 4Ivandic B T, Spanuth E, Kleber M, et al. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B- type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study [J]. Clin Chem Lab Med, 2011,49(6) : 1053-1058.
  • 5Grassi F G, Seravalle G, Quarti-Trevano F, et al. Sympathetic activation in congestibe heart failure: evidence, consequences and therapeutic implications [J]. Curr Vasc Pharmacol, 2009, 7(2) : 137-145.
  • 6Leosco D, Rengo G, laccarino G, et al. Exercise promotesangiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart [J]. Cardiovasc Res, 2008,78 ( 2 ) : 385-394.
  • 7Yeh G Y, Mccarthy E P, Wayne P M, et al. Taichi exercise in patients with chronic heart failure: a randomized clinical trial [J]. Arch Intern Med, 2011,171(8) :750-757.
  • 8Heeschen C, Hamm C W, Mitrovic V, et al. N-terminal pro- B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes [J]. Circulation, 2004,110(20) : 3206-3212.
  • 9高泉水,方杰.经皮冠状动脉介入治疗急性冠脉综合征的疗效分析[J].实用心脑肺血管病杂志,2013,33(10):133-134.
  • 10刘爱华.急性冠脉综合征患者血浆脑钠肽的检测及其临床意义[J].山东医药,2008,48(7):51-52. 被引量:4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部